Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fatty aldehydes are aliphatic, long-chain aldehydes, either saturated or unsaturated, with carbon chain lengths typically ranging from 6 to 24 carbons. They are structurally derived from fatty acids. They serve as intermediates in lipid metabolism and some oxidized short-chain variants are cytotoxic and implicated in diseases like diabetes, immunological disorders, neurodegeneration, cancer, and age-related conditions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fatty Aldehydes.